Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Scientific Beats Expectations In Q1

May 03 2021

• By Reed Miller

Earning Report Q1

Related Content

Diabetes And Diagnostics Drive Abbott’s Growth In Q1

Apr 26 2021

J&J Device Businesses Return To Growth Led By Electrophysiology And Surgery

Apr 23 2021

Boston Scientific Is Counting On COVID-19 Vaccine To Rebound In 2021

Feb 03 2021

In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US

Mar 18 2021

Boston Scientific Bets Big On Monitoring; Buys Preventice For Up To $1.25Bn

Jan 22 2021

Boston Scientific Gives Up On Lotus Edge TAVR

Nov 17 2020

Boston Scientific Divests Specialty Pharma Business

Dec 01 2020

NANS 2020: Boston Scientific Expects Neuromodulation Business Rebound In 2020

Jan 30 2020

Related Companies

Boston Scientific Corporation

Abbott

Johnson & Johnson

Edwards Lifesciences Corp.

Medtronic plc

Additional Topics

Sales & Earnings Clinical Trials Commercial Companies Deals M & A Cardiovascular Cancer Cardiology Medical Device

More from Cardiology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window